You are here

PROFUSA, INC.

Company Information
Address
345 ALLERTON AVE
SOUTH SAN FRANCISCO, CA 94080-4816
United States



Information

DUNS: 830219338

# of Employees: 31


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Development of Autonomous Glycemic Control Mechanism for Patients Suffering Glycemic Abnormalities as a Result of Critical Illnesses

    Amount: $224,864.20

    The use of continuous glucose monitors can be an invaluable management tool for patients afflicted by glycemic variability due to critical illness or trauma. Maintaining stable glucose levels enhances ...

    STTRPhase I2019Department of Defense Defense Advanced Research Projects Agency
  2. Tissue Oxygen Monitoring in Peripheral Vascular Disease

    Amount: $1,499,063.00

    DESCRIPTIONprovided by applicantThe goal of this Fast Track SBIR is to demonstrate the functionality of PROFUSAandapos s novel injectable tissue oxygen monitors in patients with peripheral arterial di ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health
  3. Late stage development and preparation of a long-term non-enzymatic continuous glucose sensor for clinical trials

    Amount: $962,340.00

    Abstract Diabetes is a complex multi factorial disease that diminishes the length and quality of life of affected individualsThe use of continuous glucose monitorsCGMcan be an invaluable management to ...

    SBIRPhase II2018Department of Health and Human Services National Institutes of Health
  4. Lactate Sensors for Continuous Physiological Monitoring

    Amount: $6,758,936.00

    The overall goal of the Phase II work is to advance novel tissue-integrating lactate sensors towards human testing as rapidly as possible (proposal does not include human testing itself). A single sen ...

    SBIRPhase II2018Department of Defense Defense Advanced Research Projects Agency
  5. Wireless Technology for Long Term Non Invasive O Sensing within Cell Encapsulation Devices in Vivo

    Amount: $224,911.00

    Summary Islet cell transplantation is an alternative therapy for the treatment of diabetes but requires the administration of immunosuppressive drugs to avoid host rejection Immunoisolation devices s ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  6. Tissue Oxygen Monitoring in Peripheral Vascular Disease

    Amount: $224,878.00

    DESCRIPTION provided by applicant The goal of this Fast Track SBIR is to demonstrate the functionality of PROFUSAandapos s novel injectable tissue oxygen monitors in patients with peripheral arteri ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  7. Long term non enzymatic glucose sensor for an artificial pancreas

    Amount: $1,496,421.00

    Project Summary Abstract Despite years of development currently available continuous glucose monitors CGMs still lack good accuracy and reliability for short term and particularly long term use in ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  8. Wearable Patch Reader for Peripheral Artery Disease

    Amount: $1,492,474.00

    Abstract The goal of this Phase II SBIR is to convert Profusa s bulky cabled optical reader into a wearable flexible disposable bandage like format that conforms to the foot for continuous monit ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  9. Real Time Oxygen Monitoring for Tissue Health Peripheral Artery Disease Application

    Amount: $1,726,829.00

    DESCRIPTION provided by applicant Continuous biochemical monitoring has the power to change currently accepted standards of care shifting the emphasis from treating illness to maintaining health ...

    STTRPhase II2016Department of Health and Human Services National Institutes of Health
  10. Real-Time Oxygen Monitoring for Tissue Health: Peripheral Artery Disease Application

    Amount: $296,345.00

    DESCRIPTION provided by applicant Continuous biochemical monitoring has the power to change currently accepted standards of care shifting the emphasis from treating illness to maintaining health ...

    STTRPhase I2015Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government